| |
| |
|
| Insider
Information: |
Shallcross Steven A |
| Relationship: |
Director |
| City: |
Germantown |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
357,217 |
|
|
Indirect Shares
|
27,321 |
|
|
| Direct
Value |
$42,467 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
384,538 |
|
|
| Total
Value |
$42,467 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -52.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Middlebrook Pharmaceuticals Corp |
MBRKQ |
Officer |
|
0 |
2003-10-15 |
27,321 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
Sr. VP, CFO, Treasurer |
2007-11-28 |
0 |
2006-12-11 |
0 |
Premium* |
|
|
Cytomedix Inc |
CMXI |
Chief Financial Officer |
2014-08-26 |
79,500 |
2014-08-20 |
0 |
Premium* |
|
|
Theriva Biologics Ord Shs |
TOVX |
CEO and CFO, Director |
2023-06-07 |
250,000 |
2019-08-23 |
0 |
Premium* |
|
|
Elys Game Technology, Corp |
ELYS |
Director |
2023-02-14 |
27,717 |
2021-01-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2023-06-07 |
4 |
B |
$0.69 |
$9,703 |
D/D |
14,000 |
250,000 |
2.81 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2023-06-06 |
4 |
B |
$0.63 |
$16,453 |
D/D |
26,000 |
236,000 |
2.81 |
- |
|
| ELYS |
Elys Game Technology, Cor... |
Director |
– • – |
2023-02-14 |
4 |
A |
$0.89 |
$20,000 |
D/D |
22,472 |
27,717 |
0 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2023-02-10 |
4 |
B |
$1.04 |
$26,075 |
D/D |
25,000 |
210,000 |
2.81 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2023-02-02 |
4 |
B |
$0.94 |
$23,513 |
D/D |
25,000 |
185,000 |
2.81 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2023-01-25 |
4 |
B |
$0.87 |
$21,825 |
D/D |
25,000 |
160,000 |
2.81 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2023-01-20 |
4 |
B |
$0.75 |
$18,705 |
D/D |
25,000 |
135,000 |
2.81 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2022-12-29 |
4 |
B |
$0.44 |
$43,700 |
D/D |
100,000 |
110,000 |
2.81 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2021-05-10 |
4 |
B |
$0.49 |
$24,595 |
D/D |
50,000 |
100,000 |
2.81 |
% |
|
| ELYS |
Elys Game Technology, Cor... |
Director |
– • – |
2021-01-22 |
4 |
A |
$5.72 |
$30,001 |
D/D |
5,245 |
5,245 |
0 |
- |
|
| TOVX |
Theriva Biologics Ord Shs |
CEO and CFO |
• • – |
2019-08-23 |
4 |
B |
$0.42 |
$20,785 |
D/D |
50,000 |
50,000 |
2.81 |
- |
|
| CMXI |
Cytomedix Inc |
Chief Financial Officer |
• – – |
2014-08-26 |
4 |
B |
$0.38 |
$10,450 |
D/D |
27,500 |
79,500 |
2.74 |
- |
|
| CMXI |
Cytomedix Inc |
Chief Financial Officer |
• – – |
2014-08-20 |
4 |
B |
$0.39 |
$20,280 |
D/D |
52,000 |
52,000 |
2.74 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-11-28 |
4 |
OE |
$0.83 |
$8,858 |
D/D |
3,300 |
3,300 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-11-28 |
4 |
AS |
$9.00 |
$29,700 |
D/D |
(3,300) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-11-16 |
4 |
AS |
$25.60 |
$2,560 |
D/D |
(100) |
2,600 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-10-16 |
4 |
AS |
$17.93 |
$59,169 |
D/D |
(3,300) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-10-16 |
4 |
OE |
$0.83 |
$8,858 |
D/D |
3,300 |
3,300 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-09-18 |
4 |
AS |
$14.81 |
$48,873 |
D/D |
(3,300) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-09-18 |
4 |
OE |
$0.83 |
$8,858 |
D/D |
3,300 |
1,569 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-08-21 |
4 |
AS |
$15.21 |
$50,193 |
D/D |
(3,300) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-08-21 |
4 |
OE |
$0.83 |
$2,926 |
D/D |
3,300 |
3,300 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-07-17 |
4 |
AS |
$20.63 |
$68,079 |
D/D |
(3,300) |
0 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-07-17 |
4 |
OE |
$0.83 |
$2,730 |
D/D |
3,300 |
3,300 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
Sr. VP, CFO, Treasurer |
• – – |
2007-06-19 |
4 |
AS |
$21.19 |
$69,927 |
D/D |
(3,300) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
